511 related articles for article (PubMed ID: 26101247)
21. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
22. Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles.
Sönmezer M; Türkçüoğlu I; Coşkun U; Oktay K
Fertil Steril; 2011 May; 95(6):2125.e9-11. PubMed ID: 21292255
[TBL] [Abstract][Full Text] [Related]
23. Response to ovarian stimulation in patients facing gonadotoxic therapy.
Johnson LN; Dillon KE; Sammel MD; Efymow BL; Mainigi MA; Dokras A; Gracia CR
Reprod Biomed Online; 2013 Apr; 26(4):337-44. PubMed ID: 23415997
[TBL] [Abstract][Full Text] [Related]
24. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization.
Azim AA; Costantini-Ferrando M; Lostritto K; Oktay K
J Clin Endocrinol Metab; 2007 Jun; 92(6):2197-200. PubMed ID: 17356042
[TBL] [Abstract][Full Text] [Related]
25. Twin delivery after IVF-ET with variable dose letrozole-FSH protocol of lower estradiol in a patient previously treated for breast cancer: a case report.
Zhang CJ; Zhang Y; Hu GZ; Diao H
Eur J Gynaecol Oncol; 2016; 37(2):278-81. PubMed ID: 27172763
[TBL] [Abstract][Full Text] [Related]
26. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
[TBL] [Abstract][Full Text] [Related]
27. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
Noriega-Portella L; Noriega-Hoces L; Delgado A; Rubio J; Gonzales-Castañeda C; Gonzales GF
Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
[TBL] [Abstract][Full Text] [Related]
28. High yield of oocytes without an increase in circulating estradiol levels in breast cancer patients treated with follicle-stimulating hormone and aromatase inhibitor in standard gonadotropin-releasing hormone analogue protocols.
Ben-Haroush A; Farhi J; Ben-Aharon I; Sapir O; Pinkas H; Fisch B
Isr Med Assoc J; 2011 Dec; 13(12):753-6. PubMed ID: 22332446
[TBL] [Abstract][Full Text] [Related]
29. Random-start ovarian stimulation in patients with cancer.
Cakmak H; Rosen MP
Curr Opin Obstet Gynecol; 2015 Jun; 27(3):215-21. PubMed ID: 25919235
[TBL] [Abstract][Full Text] [Related]
30. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma.
Azim A; Oktay K
Fertil Steril; 2007 Sep; 88(3):657-64. PubMed ID: 17428480
[TBL] [Abstract][Full Text] [Related]
31. Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience.
Cardozo ER; Thomson AP; Karmon AE; Dickinson KA; Wright DL; Sabatini ME
J Assist Reprod Genet; 2015 Apr; 32(4):587-96. PubMed ID: 25595540
[TBL] [Abstract][Full Text] [Related]
32. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome.
Casper RF; Mitwally MF
Clin Obstet Gynecol; 2011 Dec; 54(4):685-95. PubMed ID: 22031258
[TBL] [Abstract][Full Text] [Related]
33. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation.
Oktay K
J Clin Oncol; 2005 Jun; 23(16):3858-9. PubMed ID: 15911867
[No Abstract] [Full Text] [Related]
34. Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone.
Lee S; Ozkavukcu S; Heytens E; Moy F; Alappat RM; Oktay K
J Assist Reprod Genet; 2011 Jul; 28(7):651-6. PubMed ID: 21573682
[TBL] [Abstract][Full Text] [Related]
35. Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial.
Azmoodeh A; Pejman Manesh M; Akbari Asbagh F; Ghaseminejad A; Hamzehgardeshi Z
Glob J Health Sci; 2015 Sep; 8(4):244-52. PubMed ID: 26573024
[TBL] [Abstract][Full Text] [Related]
36. Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment.
Dolmans MM; Hollanders de Ouderaen S; Demylle D; Pirard C
J Assist Reprod Genet; 2015 Aug; 32(8):1233-7. PubMed ID: 26174124
[TBL] [Abstract][Full Text] [Related]
37. Randomized controlled trial comparing superovulation with letrozole versus recombinant follicle-stimulating hormone combined with intrauterine insemination for couples with unexplained infertility who had failed clomiphene citrate stimulation and intrauterine insemination.
Gregoriou O; Vlahos NF; Konidaris S; Papadias K; Botsis D; Creatsas GK
Fertil Steril; 2008 Sep; 90(3):678-83. PubMed ID: 17961561
[TBL] [Abstract][Full Text] [Related]
38. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
Chien AJ; Chambers J; Mcauley F; Kaplan T; Letourneau J; Hwang J; Kim MO; Melisko ME; Rugo HS; Esserman LJ; Rosen MP
Breast Cancer Res Treat; 2017 Aug; 165(1):151-159. PubMed ID: 28503722
[TBL] [Abstract][Full Text] [Related]
39. Techniques for fertility preservation in patients with breast cancer.
Dunn L; Fox KR
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):68-73. PubMed ID: 19125006
[TBL] [Abstract][Full Text] [Related]
40. Fertility preservation in women with breast cancer.
Rodriguez-Wallberg KA; Oktay K
Clin Obstet Gynecol; 2010 Dec; 53(4):753-62. PubMed ID: 21048442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
